(Q46023229)

English

First artemisinin-based antimalarial combination approved for U.S. market.

scientific article published in May 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19420302

title

First artemisinin-based antimalarial combination approved for U.S. market. (English)

1 reference

stated in

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19420302

0 references

0 references

1

Cheryl A Thompson

1 reference

stated in

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19420302

publication date

1 May 2009

1 reference

stated in

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19420302

published in

American Journal of Health-System Pharmacy

1 reference

stated in

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19420302

volume

66

1 reference

stated in

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19420302

issue

10

1 reference

stated in

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19420302

page(s)

880

1 reference

stated in

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19420302

Identifiers

DOI

10.2146/NEWS090041

1 reference

stated in

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19420302

PubMed ID

19420302

1 reference

stated in

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19420302

(Q46023229)

First artemisinin-based antimalarial combination approved for U.S. market.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)